Hoshikawa H, Sawamura T, Kakutani M, Aoyama T, Nakamura T, Masaki T
Department of Pharmacology, Faculty of Medicine, Kyoto University, Japan.
Biochem Biophys Res Commun. 1998 Apr 28;245(3):841-6. doi: 10.1006/bbrc.1998.8526.
We cloned mouse LOX-1 cDNA to take advantage of a gene-targeting technique to clarify the role of LOX-1 in vivo. Mouse LOX-1 was composed of 363 amino acids and had a C-type lectin domain type II membrane protein structure. Mouse LOX-1 had triple repeats of the sequence in the extracellular "Neck domain," which is unlike human and bovine LOX-1. LOX-1 bound oxidized LDL with two classes of binding affinity in the presence of serum. The binding component with the higher affinity showed the lowest value of Kd among the known receptors for oxidized LDL. In the absence of serum, the high affinity component disappeared, suggesting that an unknown co-factor in serum is essential for efficient uptake of oxidized LDL by endothelial cells. A low concentration of unlabeled oxidized LDL displaced 125I-labeled oxidized LDL more efficiently in the presence of serum than in the absence of serum. The co-factor in the serum may be involved in the pathophysiology of atherosclerosis in addition to the oxidation of LDL.
我们克隆了小鼠LOX-1 cDNA,以利用基因靶向技术阐明LOX-1在体内的作用。小鼠LOX-1由363个氨基酸组成,具有II型C型凝集素结构域膜蛋白结构。小鼠LOX-1在细胞外“颈部结构域”具有该序列的三重重复,这与人和牛的LOX-1不同。在血清存在的情况下,LOX-1以两类结合亲和力结合氧化型低密度脂蛋白(ox-LDL)。在已知的ox-LDL受体中,具有较高亲和力的结合成分显示出最低的解离常数(Kd)值。在无血清的情况下,高亲和力成分消失,这表明血清中一种未知的辅助因子对于内皮细胞有效摄取ox-LDL至关重要。在血清存在的情况下,低浓度的未标记ox-LDL比在无血清的情况下更有效地取代了125I标记的ox-LDL。血清中的辅助因子除了参与LDL的氧化外,可能还参与动脉粥样硬化的病理生理过程。